C
IMGN

Covestor’s Immunogen Inc IMGN Stock Holding History

Covestor’s Portfolio IMGN Stock Details IMGN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q1 		– Sell
-509
Closed -$15K – 2909
2023
Q4 		$15K Sell
509
-1
-0.2% -$20 0.01% 1323
2023
Q3 		$8K Buy
510
+486
+2,025% +$8.08K 0.01% 1595
2023
Q2 		$0 Hold
24
– – ﹤0.01% 2801
2023
Q1 		$0 Hold
24
– – ﹤0.01% 2736
2022
Q4 		$0 Sell
24
-14
-37% -$76 ﹤0.01% 2759
2022
Q3 		$0 Sell
38
-7
-16% -$37 ﹤0.01% 2779
2022
Q2 		$0 Sell
45
-12
-21% -$52 ﹤0.01% 2490
2022
Q1 		$0 Sell
57
-14
-20% -$78 ﹤0.01% 2521
2021
Q4 		$1K Buy
+71
New +$441 ﹤0.01% 2032

Other funds holding IMGN

IA
IFP Advisors Tampa, Florida $5.54B AUM 27.43% 1-Year Est. Return
MG
Mather Group Chicago, Illinois $10B AUM 15.14% 1-Year Est. Return
HNB
Huntington National Bank Columbus, Ohio $18.1B AUM 24.69% 1-Year Est. Return

Covestor's IMGN Position: Q1 2024 in Review

Covestor sold out of Immunogen Inc (IMGN) in Q1 2024, closing a stake of 509 shares — an estimated $15K sold.

Covestor first reported a position in IMGN in Q4 2021 and held it in 9 quarters. The position peaked at $15K in Q4 2023. 3 funds tracked by Wall St. Rank hold IMGN as of Q1 2024.

  • Covestor reported no remaining Immunogen Inc position as of Q1 2024 after selling out during the quarter.
  • Covestor sold 509 Immunogen Inc shares in Q1 2024, an estimated $15K.
  • Covestor first reported a position in Immunogen Inc in Q4 2021 and held it in 9 quarters.
  • Covestor's Immunogen Inc position peaked at $15K in Q4 2023.
  • 3 funds tracked by Wall St. Rank held Immunogen Inc as of Q1 2024.

Based on Covestor's 13F filing for Q1 2024, filed 10 May 2024.